David Weigner

Area of research

Cognitive Neuroscience · Pharmacology

Research interest

Research interests include Ketamine, Medicine, Randomized controlled trial, Meta-analysis, Major depressive disorder, and Lamotrigine.

h-index

—

citations

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

Modulatory Effects of Ketamine and Lamotrigine on Cognition: Emotion Interaction in the Brain

Neuropsychobiology 2023cited by 9position: middledoi

Region- and time- specific effects of ketamine on cerebral blood flow: a randomized controlled trial

Neuropsychopharmacology 2023cited by 6position: middledoi

Does route of administration affect antidepressant efficacy of ketamine? A meta-analysis of double-blind randomized controlled trials comparing intravenous and intranasal administration

Journal of Psychiatric Research 2022cited by 9position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Matti Gärtner · MSB Medical School Berlin3 papers (2022–2023)Simone Grimm · University of Zurich3 papers (2022–2023)— · 3 papers (2022–2023)Anne Weigand · MSB Medical School Berlin2 papers (2023–2023)Christian Keicher · Charité - Universitätsmedizin Berlin2 papers (2023–2023)Luisa Carstens · MSB Medical School Berlin2 papers (2023–2023)Christian F. Beckmann · Radboud University Nijmegen2 papers (2023–2023)Maarten Mennes · Radboud University Nijmegen2 papers (2023–2023)— · 2 papers (2023–2023)Andreas Wunder · Charité - Universitätsmedizin Berlin2 papers (2023–2023)— · 1 papers (2022–2022)